Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGAD in Adults: The MOGADOR2 Study.
Romain DeschampsJessica GuillaumeJonathan CironBertrand AudoinAurélie RuetElisabeth MaillartJulie PiqueLakhdar BenyahyaDavid-Axel LaplaudLaure MichelNicolas CollonguesMikael CohenXavier AyrignacEric ThouvenotHelene ZephirBertrand BourreCaroline Froment TiliketeThibault MoreauPaul CantagrelPhilippe KerschenSebastien CabassonNicolas MaubeugeKarolina HankiewiczChantal NifleEric BergerHana MegherbiLaurent MagyFrederic KlapczynskiMariana Sarov RiviereClaire GiannesiniLorraine HamelinMarianne GirouxPierre BrangerAude MauroussetGuillaume MatheyMaximilien MoulinNicolas MéléCaroline PapeixRomain Marigniernull nullPublished in: Neurology (2024)
This study provides Class III evidence that initiating maintenance therapy from the first attack in patients with MOGAD reduces the relapse risk.